14-day Premium Trial Subscription Sign Up For FreeGet Free

BioShares Biotechnology Clinical Trials Fund Forecast NASDAQ:BBC

$44.29 (-0.43%)

Volume: 1k

Closed: Oct 22, 2021

Hollow Logo Score: 0.054

BioShares Biotechnology Clinical Trials Fund Forecast

$44.29 (-0.43%)

Volume: 1k

Closed: Oct 22, 2021

Score Hollow Logo 0.054

BioShares Biotechnology Clinical Trials Fund Price (Quote) NASDAQ:BBC

$44.29 ( -0.43% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $43.54 $48.57 Friday, 22nd Oct 2021 BBC stock ended at $44.29. This is 0.43% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 1.73% from a day low at $43.54 to a day high of $44.29.
90 days $42.41 $49.28
52 weeks $38.52 $62.60

Historical BioShares Biotechnology Clinical Trials Fund prices

Date Open High Low Close Volume
2021-10-22 $43.89 $44.29 $43.54 $44.29 1 102
2021-10-21 $44.48 $44.68 $44.48 $44.48 3 373
2021-10-20 $44.27 $44.62 $44.08 $44.08 2 377
2021-10-19 $44.40 $44.59 $44.18 $44.33 3 673
2021-10-18 $44.99 $44.99 $44.02 $44.10 4 731
2021-10-15 $45.52 $45.52 $45.24 $45.24 932
2021-10-14 $46.00 $46.22 $45.80 $45.80 958
2021-10-13 $45.41 $45.41 $44.83 $45.30 950
2021-10-12 $44.70 $45.43 $44.70 $45.10 3 156
2021-10-11 $44.58 $44.80 $44.58 $44.72 538
2021-10-08 $44.61 $44.77 $44.35 $44.57 19 692
2021-10-07 $45.24 $45.24 $44.70 $44.81 1 724
2021-10-06 $44.78 $44.78 $44.49 $44.49 1 062
2021-10-05 $45.00 $45.39 $45.00 $45.15 1 505
2021-10-04 $45.78 $45.78 $45.07 $45.28 5 189
2021-10-01 $45.18 $45.97 $45.16 $45.97 1 170
2021-09-30 $45.92 $46.15 $45.57 $45.70 6 060
2021-09-29 $46.63 $46.63 $46.63 $46.63 0
2021-09-28 $47.10 $47.11 $46.63 $46.63 1 158
2021-09-27 $48.20 $48.57 $48.20 $48.35 1 710
2021-09-24 $47.99 $47.99 $47.59 $47.59 1 633
2021-09-23 $48.12 $48.51 $47.89 $48.48 2 762
2021-09-22 $47.09 $47.82 $47.05 $47.32 12 261
2021-09-21 $47.27 $47.65 $47.27 $47.39 1 705
2021-09-20 $47.49 $47.49 $46.18 $46.72 4 264
2021-09-17 $47.59 $48.56 $47.52 $48.56 1 630
2021-09-16 $47.44 $47.91 $47.13 $47.89 1 964
2021-09-15 $46.99 $47.70 $46.99 $47.60 5 347
2021-09-14 $48.00 $48.00 $47.12 $47.12 363
2021-09-13 $48.04 $48.50 $47.43 $47.79 3 326
2021-09-10 $48.23 $48.34 $48.00 $48.00 2 969
2021-09-09 $47.89 $48.79 $47.89 $48.29 4 539
2021-09-08 $48.02 $48.02 $47.69 $47.90 875
2021-09-07 $49.13 $49.13 $48.16 $48.50 3 692
2021-09-03 $49.00 $49.00 $48.03 $48.17 1 940
2021-09-02 $48.56 $49.28 $48.56 $49.28 7 418
2021-09-01 $48.38 $48.59 $48.20 $48.51 2 649
2021-08-31 $47.89 $47.93 $47.49 $47.74 2 975
2021-08-30 $47.70 $47.80 $47.22 $47.22 1 156
2021-08-27 $47.30 $47.62 $47.30 $47.45 2 295
2021-08-26 $46.80 $47.24 $46.17 $46.18 3 585
2021-08-25 $45.84 $46.37 $45.84 $46.37 5 305
2021-08-24 $45.75 $45.92 $45.28 $45.92 2 361
2021-08-23 $44.44 $46.11 $44.44 $45.96 3 016
2021-08-20 $43.57 $43.61 $43.57 $43.61 733
2021-08-19 $43.35 $43.35 $42.41 $42.41 2 895
2021-08-18 $44.07 $44.84 $43.74 $43.74 3 775
2021-08-17 $43.36 $44.34 $43.36 $44.34 4 778
2021-08-16 $44.99 $44.99 $43.84 $43.84 2 032
2021-08-13 $45.45 $45.93 $45.25 $45.25 2 865

About BioShares Biotechnology Clinical Trials Fund

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT